Form 3/A - Initial statement of beneficial ownership of securities: [Amend]
SEC Accession No. 0001474506-25-000108
Filing Date
2025-06-11
Accepted
2025-06-11 16:11:52
Documents
1
Period of Report
2025-03-04

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 3/A  
1 PRIMARY DOCUMENT primary_doc.xml 3/A 9701
  Complete submission text file 0001474506-25-000108.txt   11343
Mailing Address 2 EAST BROAD STREET 2ND FLOOR HOPEWELL NJ 08525
Business Address 2 EAST BROAD STREET 2ND FLOOR HOPEWELL NJ 08525 848-201-5010
Apimeds Pharmaceuticals US, Inc. (Issuer) CIK: 0001894525 (see all company filings)

EIN.: 851099700 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address ROOM 613, DIGITAL-RO 130, 6F GEUMCHEON-GU SEOUL M5 08580
Business Address ROOM 613, DIGITAL-RO 130, 6F GEUMCHEON-GU SEOUL M5 08580 82-70-7600-7007
Inscobee Inc. (Reporting) CIK: 0002057997 (see all company filings)

Type: 3/A | Act: 34 | File No.: 001-42545 | Film No.: 251040125